{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:29:47Z","timestamp":1761744587168},"reference-count":45,"publisher":"Japan Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1507\/endocrj.ej17-0245","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T22:09:58Z","timestamp":1504303798000},"page":"1105-1114","source":"Crossref","is-referenced-by-count":12,"title":["Impact of fatty liver disease and metabolic syndrome on incident type 2 diabetes; a population based cohort study"],"prefix":"10.1507","volume":"64","author":[{"given":"Kazuteru","family":"Mitsuhashi","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Hamaguchi","sequence":"additional","affiliation":[{"name":"Department of Diabetology, Kameoka Municipal Hospital, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Obora","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Murakami Memorial Hospital, Asahi University, Gifu, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Murakami Memorial Hospital, Asahi University, Gifu, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","unstructured":"1. Espeland MA, Glick HA, Bertoni A, Brancati FL, Bray GA, <i>et al<\/i>. (2014) Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes. <i>Diabetes Care<\/i> 37: 2548-2556."},{"key":"2","unstructured":"2. Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, Gobin R, <i>et al<\/i>. (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. <i>Lancet<\/i> 375: 2215-2222."},{"key":"3","unstructured":"3. Narayan KM, Gregg EW, Fagot-Campagna A, Engelgau MM, Vinicor F (2000) Diabetes--a common, growing, serious, costly, and potentially preventable public health problem. <i>Diabetes Res Clin Pract<\/i> 50: S77-S84."},{"key":"4","unstructured":"4. Yki-J&auml;rvinen H (2014) Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. <i>Lancet Diabetes Endocrinol<\/i> 2: 901-910."},{"key":"5","unstructured":"5. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, <i>et al<\/i>. (2005) The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. <i>Ann Intern Med<\/i> 143: 722-728."},{"key":"6","unstructured":"6. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM (2003) The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. <i>Diabetes Care<\/i> 26: 3153-3159."},{"key":"7","unstructured":"7. Hanley AJ, Karter AJ, Williams K, Festa A, D&#039;Agostino RB Jr, <i>et al<\/i>. (2005) Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. <i>Circulation<\/i> 112: 3713-3721."},{"key":"8","unstructured":"8. Shibata M, Kihara Y, Taguchi M, Tashiro M, Otsuki M (2007) Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. <i>Diabetes Care<\/i> 30: 2940-2944."},{"key":"9","unstructured":"9. Fukuda T, Hamaguchi M, Kojima T, Mitsuhashi K, Hashimoto Y, <i>et al<\/i>. (2016) Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men. <i>Eur J Gastroenterol Hepatol<\/i> 28: 1443-1449."},{"key":"10","unstructured":"10. Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, <i>et al<\/i>. (2010) Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. <i>Hepatology<\/i> 51: 1979-1987."},{"key":"11","unstructured":"11. Hashimoto Y, Hamaguchi M, Kojima T, Ohshima Y, Ohbora A, <i>et al<\/i>. (2015) Modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study. <i>J Gastroenterol Hepatol<\/i> 30: 546-552."},{"key":"12","unstructured":"12. Ju&aacute;rez-Rojas JG, Medina-Urrutia AX, Jorge-Galarza E, Gonz&aacute;lez-Salazar C, Kimura-Hayama E, <i>et al<\/i>. (2013) Fatty liver increases the association of metabolic syndrome with diabetes and atherosclerosis. <i>Diabetes Care<\/i> 36: 1726-1728."},{"key":"13","unstructured":"13. McCullough AJ (2004) The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. <i>Clin Liver Dis<\/i> 8: 521-533."},{"key":"14","unstructured":"14. American Diabetes Association (2013) Diagnosis and classification of diabetes mellitus. <i>Diabetes Care<\/i> 36 Suppl 1: S67-S74."},{"key":"15","unstructured":"15. Hashimoto Y, Hamaguchi M, Fukuda T, Nakamura N, Ohbora A, <i>et al<\/i>. (2016) BMI history and risk of incident fatty liver: a population-based large-scale cohort study. <i>Eur J Gastroenterol Hepatol<\/i> 28: 1188-1193."},{"key":"16","unstructured":"16. Fukuda Y, Hashimoto Y, Hamaguchi M, Fukuda T, Nakamura N, <i>et al<\/i>. (2016) Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study. <i>Liver Int<\/i> 36: 713-720."},{"key":"17","unstructured":"17. Aaron DJ, Kriska AM, Dearwater SR, Cauley JA, Metz KF, <i>et al<\/i>. (1995) Reproducibility and validity of an epidemiologic questionnaire to assess past year physical activity in adolescents. <i>Am J Epidemiol<\/i> 142: 191-201."},{"key":"18","unstructured":"18. Ryu S, Chang Y, Kim DI, Kim WS, Suh BS (2007) gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. <i>Clin Chem<\/i> 53: 71-77."},{"key":"19","unstructured":"19. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, <i>et al<\/i>. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. <i>Circulation<\/i> 120: 1640-1645."},{"key":"20","unstructured":"20. Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, <i>et al<\/i>. (2007) The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. <i>Am J Gastroenterol<\/i> 102: 2708-2715."},{"key":"21","unstructured":"21. Aung K, Lorenzo C, Hinojosa MA, Haffner SM (2014) Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. <i>J Clin Endocrinol Metab<\/i> 99: 462-468."},{"key":"22","unstructured":"22. Goessling W, Massaro JM, Vasan RS, D&#039;Agostino RB Sr, Ellison RC, <i>et al<\/i>. (2008) Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. <i>Gastroenterology<\/i> 135: 1935-1944."},{"key":"23","unstructured":"23. Sung KC, Jeong WS, Wild SH, Byrne CD (2012) Combined influence of insulin resistance, overweight\/obesity, and fatty liver as risk factors for type 2 diabetes. <i>Diabetes Care<\/i> 35: 717-722."},{"key":"24","unstructured":"24. Fukuda T, Hamaguchi M, Kojima T, Hashimoto Y, Ohbora A, <i>et al<\/i>. (2016) The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals. <i>Liver Int<\/i> 36: 275-283."},{"key":"25","unstructured":"25. Bae JC, Kim SK, Han JM, Kwon S, Lee DY, <i>et al<\/i>. (2017) Additive effect of non-alcoholic fatty liver disease on the development of diabetes in individuals with metabolic syndrome. <i>Diabetes Res Clin Pract<\/i> 129: 136-143."},{"key":"26","unstructured":"26. Tokita Y, Maejima Y, Shimomura K, Takenoshita S, Ishiyama N, <i>et al<\/i>. (2017) Non-alcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-aged Japanese Men and Women. <i>Intern Med<\/i> 56: 763-771."},{"key":"27","unstructured":"27. Byrne CD, Targher G (2014) Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease. <i>Arterioscler Thromb Vasc Biol<\/i> 34: 1155-1161."},{"key":"28","unstructured":"28. Ruderman NB, Carling D, Prentki M, Cacicedo JM (2013) AMPK, insulin resistance, and the metabolic syndrome. <i>J Clin Invest<\/i> 123: 2764-2772."},{"key":"29","unstructured":"29. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S (2007) Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. <i>Diabetes<\/i> 56: 1010-1013."},{"key":"30","unstructured":"30. Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, <i>et al<\/i>. (2012) Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. <i>JAMA<\/i> 308: 1150-1159."},{"key":"31","unstructured":"31. Kato K, Takamura T, Takeshita Y, Ryu Y, Misu H, <i>et al<\/i>. (2014) Ectopic fat accumulation and distant organ-specific insulin resistance in Japanese people with nonalcoholic fatty liver disease. <i>PLoS One<\/i> 9: e92170."},{"key":"32","unstructured":"32. Cusi K (2010) The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. <i>Curr Diab Rep<\/i> 10: 306-315."},{"key":"33","unstructured":"33. Kim JK, Gavrilova O, Chen Y, Reitman ML, Shulman GI (2000) Mechanism of insulin resistance in A-ZIP\/F-1 fatless mice. <i>J Biol Chem<\/i> 275: 8456-8460."},{"key":"34","unstructured":"34. Sniderman AD, Bhopal R, Prabhakaran D, Sarrafzadegan N, Tchernof A (2007) Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. <i>Int J Epidemiol<\/i> 36: 220-225."},{"key":"35","unstructured":"35. Oh KJ, Lee DS, Kim WK, Han BS, Lee SC, <i>et al<\/i>. (2017) Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and Hepatokines. <i>Int J Mol Sci<\/i> 18: 8."},{"key":"36","unstructured":"36. Misu H, Takamura T, Takayama H, Hayashi H, Matsuzawa-Nagata N, <i>et al<\/i>. (2010) A liver-derived secretory protein, selenoprotein P, causes insulin resistance. <i>Cell Metab<\/i> 12: 483-495."},{"key":"37","unstructured":"37. Wu HT, Ou HY, Hung HC, Su YC, Lu FH, <i>et al<\/i>. (2016) A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes. <i>Diabetologia<\/i> 59: 1732-1742."},{"key":"38","unstructured":"38. Lieber CS (2004) Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. <i>Alcohol<\/i> 34: 9-19."},{"key":"39","unstructured":"39. Knott C, Bell S, Britton A (2015) Alcohol Consumption and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of More Than 1.9 Million Individuals From 38 Observational Studies. <i>Diabetes Care<\/i> 38: 1804-1812."},{"key":"40","unstructured":"40. Suzuki A, Angulo P, St Sauver J, Muto A, Okada T, <i>et al<\/i>. (2007) Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia. <i>Am J Gastroenterol<\/i> 102: 1912-1919."},{"key":"41","unstructured":"41. Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, <i>et al<\/i>. (2008) Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. <i>Hepatology<\/i> 48: 792-798."},{"key":"42","unstructured":"42. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, <i>et al<\/i>. (2003) Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. <i>Hepatology<\/i> 37: 1286-1292."},{"key":"43","unstructured":"43. Sumida Y, Yoneda M, Hyogo H, Itoh Y, Ono M, Fujii H, <i>et al<\/i>. (2012) Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. <i>BMC Gastroenterol<\/i>. 12:2."},{"key":"44","unstructured":"44. Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, <i>et al<\/i>. (2011) Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. <i>Hepatology<\/i> 54: 1082-1090."},{"key":"45","unstructured":"45. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S (2003) Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. <i>J Gastroenterol<\/i> 38: 954-961."}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/11\/64_EJ17-0245\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T04:51:15Z","timestamp":1512190275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/11\/64_EJ17-0245\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej17-0245","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}